Safety and Efficacy of AGN 203818 in Patients With Painful Diabetic Peripheral Neuropathy
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
This study will explore the safety and effectiveness of different doses of AGN 203818 in
treating pain in patients with painful diabetic peripheral neuropathy